MedPath

Effect of magnesium, vitamin D, vitamin C, zinc and calcium Supplements on cardiometabolic parameters in infertile women with polycystic ovary syndrome.

Phase 3
Conditions
polycystic ovarian syndrome.
Polycystic ovarian syndrome
Registration Number
IRCT2013110615307N1
Lead Sponsor
Hamadan Univesity of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

Abnormal menstrual cycles, polycystic ovaries in sonography, chemical or clinical signs of hyper androgenism.
Exclusion criteria:
History of any underlying and chronic disease, history of pelvic or abdominal surgery, partner's infertility, abnormal level of serum prolactin, smoking, current or previous using of statins in last 2 months, insuline usage, corticosteroid usage, history of neoplastic disease.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Heart condition. Timepoint: 2 months after intervention. Method of measurement: Echocardiography.
Secondary Outcome Measures
NameTimeMethod
Serum lipids level. Timepoint: tow months after intervention. Method of measurement: Patients blood sampel.;Serum insullin level. Timepoint: tow months after intervention. Method of measurement: Patients blood samples patients.
© Copyright 2025. All Rights Reserved by MedPath